| Literature DB >> 35437455 |
Zetong Zhang1,2, Chen Zhao3,4, Ruijie Zhang5, Yiyang Wang3,4, Yanzhu Hu3,4, Qiang Zhou3,4, Pei Li3,4.
Abstract
Intervertebral disc degeneration (IDD) is closely related to osmolarity, which fluctuates with daily activities, and hyperosmolarity may be a contributor to nucleus pulposus (NP) cells apoptosis. Aquaporin-3 (AQP-3) belongs to the family of aquaporins and mainly transports water and other small molecular proteins, which is reduced with the aging of the intervertebral disc. ERK1/2 pathway is one type of mitogen-activated protein kinase (MAPK) and is associated with cellular apoptosis. This study was aimed to investigate the effects of AQP-3 on NP cells apoptosis induced by a hyperosmolarity and focused on the role of the ERK1/2 signaling pathway. We found that NP apoptosis could be induced by hyperosmolarity (550 mOsm/kg), and downregulation of AQP-3 and inhibition of ERK1/2 could be simultaneously observed. Therefore, lentivirus was used to enhance the expression of AQP-3 to compare apoptosis between AQP-3-overexpressed NP cells and the control NP cells. The results showed that apoptosis could be alleviated by overexpression of AQP-3 and the activity of ERK1/2 could also be promoted. Furthermore, we found that the inhibitor U0126 could partly aggravate apoptosis of the AQP-3-overexpressed NP cells. In summary, our results suggested that overexpression of AQP-3 could protect against hyperosmolarity-induced NP cell apoptosis via promoting the activity of the ERK1/2 pathway. This study may shed light on a better understanding of the pathologic mechanism of IDD and bring AQP-3 into the therapeutic approaches for IDD treatment.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35437455 PMCID: PMC9013301 DOI: 10.1155/2022/1639560
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 2.667
Primers of target genes.
| Gene | Forward (5′-3′) | Reverse (5′-3′) |
|---|---|---|
|
| CCGCGAGTACAACCTTCTTG | TGACCCATACCCACCATCAC |
| Bcl-2 | GGGGCTACGAGTGGGATACT | GACGGTAGCGACGAGAGAAG |
| Bax | GGCGAATTGGCGATGAACTG | CCCAGTTGAAGTTGCCGTCT |
| Caspase-3 | GGAGCTTGGAACGCGAAGA | ACACAAGCCCATTTCAGGGT |
| AQP-3 | AGAAGGAGTTGATGAACCGTTGCG | AACCACAGCCGAACATCACAAGG |
Figure 1Hyperosmolarity inhibited NP cell proliferation and promoted NP cell apoptosis. (a) The proliferation of rat NP cells detected by CCK-8. (b) Flow cytometry analysis of cell apoptosis rate under different osmotic pressures (330 mOsm/kg and 550 mOsm/kg). Data are expressed as mean ± SD. (A) indicates a significant difference (p < 0.05) when compared with 330 mOsm/kg.
Figure 2Hyperosmolarity increased the expression of proapoptosis molecules (Bax and caspase-3/cleaved caspase-3) and decreased the expression of antiapoptosis molecules (Bcl-2). (a,b) Real-time PCR and western blotting analysis of proapoptosis (Bax and caspase-3/cleaved caspase-3) and antiapoptosis (Bcl-2) molecules under different osmotic pressures (330 mOsm/kg and 550 mOsm/kg), respectively. Data are expressed as mean ± SD. (A) indicates a significant difference (p < 0.05) when compared with 330 mOsm/kg.
Figure 3Hyperosmolarity decreased AQP-3 expression and inhibited activation of ERK1/2 signaling in NP cells. (a) Immunocytochemical detection of AQP-3 expression of NP cells under different osmotic pressures (330 mOsm/kg and 550 mOsm/kg). (b, c) Real-time PCR and western blotting analysis of AQP3 expression under different osmolarity (330 mOsm/kg and 550 mOsm/kg), respectively. (d) Western blotting analysis of ERK1/2 activation under different osmotic pressures (330 mOsm/kg and 550 mOsm/kg). Data are expressed as mean ± SD. (A) indicates a significant difference (p < 0.05) when compared with 330 mOsm/kg.
Figure 4Verification of the efficacy of AQP-3 overexpression. (a) Observation of green fluorescent protein under an inverted fluorescence microscope. (b, c) Verification of the efficacy of AQP3 overexpression in NP cells using real-time PCR and western blotting assays. NP-CN: NP cells without transfection used as the controls. NP-AQP-3-NC: NP cells transfected with negative vectors. NP-AQP-3: NP cells with AQP-3 overexpression. Data are expressed as mean ± SD. (A) indicates a significant difference (p < 0.05) when compared with the control group.
Figure 5AQP-3 overexpression promoted activation of ERK1/2 signaling and alleviated hyperosmolarity-induced apoptosis. (a) Western blotting analysis of ERK1/2 and p-ERK1/2 expression in AQP-3 overexpressed NP cells under a hyperosmolarity (550 mOsm/kg). (b) Flowcytometry analysis of NP cell apoptosis ratio. (c) and (d): real-time PCR and western blotting analysis of proapoptosis (Bax and caspase 3/cleaved caspase 3) and antiapoptosis (Bcl-2) molecules under different osmotic pressures (330 mOsm/kg and 550 mOsm/kg), respectively. NP-AQP-3 + 330: AQP3 overexpressed NP cells cultured in 330 mOsm/kg. NP-AQP-3 + 550: AQP3 overexpressed NP cells cultured in 550 mOsm/kg. NP-AQP-3-NC + 550: NP cells without transfection (NP-CN) cultured in 550 mOsm/kg. Data are expressed as mean ± SD. (A) indicates a significant difference (p < 0.05) when compared with the group of NP-AQP-3 + 330. (B) indicates a significant difference (p < 0.05) when compared with the group of NP-AQP-3 + 550.
Figure 6Inhibition of the ERK1/2 pathway promoted apoptosis of AQP-3 overexpressed NP cells under hyper-osmolarity. (a) Flow cytometry analysis of cell apoptosis rate under hyperosmolarity. (b) and (c): real-time PCR and western blotting analysis of proapoptosis (Bax and caspase-3/cleaved caspase-3) and antiapoptosis (Bcl-2) molecules under a hyperosmolarity, respectively. NP-AQP-3 + 550: AQP3 overexpressed NP cells cultured in 550 mOsm/kg; NP-AQP-3 + 550 + U0126: AQP3 overexpressed NP cells cultured in 550 mOsm/kg medium containing U0126; NP-CN + 550 + U0126: NP cells without transfection (NP-CN) cultured in 550 mOsm/kg medium containing U0126. (A) indicates a significant difference (p < 0.05) when compared with the group of NP-AQP-3 + 550. (B) indicates a significant difference (p < 0.05) when compared with the group of NP-AQP-3 + 550 + U0126.